XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 9 - Share-based Compensation
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

9. Share-based Compensation

 

Our Fourth Amended and Restated 2006 Stock Option and Incentive Plan allows for granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, performance-based restricted stock units, unrestricted stock awards, and deferred stock awards to our officers, employees, directors and consultants. The components of share-based compensation expense included in the consolidated statements of operations are as follows:

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(in thousands)

   

(in thousands)

 

Stock option awards

  $ 732     $ 671     $ 1,473     $ 1,333  

Restricted stock units

    573       485       1,134       962  

Performance-based restricted stock units

    304       156       612       307  
                                 

Total share-based compensation

  $ 1,609     $ 1,312     $ 3,219     $ 2,602  

 

 

Stock-based compensation is included in our consolidated statements of operations as follows:

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2024

   

2023

   

2024

   

2023

 
   

(in thousands)

   

(in thousands)

 

Cost of sales

  $ 228     $ 166     $ 439     $ 336  

Sales and marketing

    274       250       545       464  

General and administrative

    943       768       1,908       1,545  

Research and development

    164       128       327       257  
                                 

Total stock-based compensation

  $ 1,609     $ 1,312     $ 3,219     $ 2,602  

 

We did not grant any options during the six months ended June 30, 2024. During the six months ended June 30, 2023, we granted options for the purchase of 1,660 shares of our common stock. During the six months ended June 30, 2024 and 2023, we granted restricted stock units of 222 and 765, respectively. We did not grant any performance-based restricted stock units during the six months ended June 30, 2024. During the six months ended June 30, 2023, we granted performance-based restricted stock units of 310. We issued 147,540 and 179,775 shares of common stock following the exercise or vesting of underlying stock options, restricted stock units and performance-based restricted stock units during the six months ended June 30, 2024 and 2023, respectively.